Company Filing History:
Years Active: 2022-2025
Title: Peiguo Yang: Innovator in GTPase-Activating Protein Research
Introduction
Peiguo Yang is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of molecular biology, particularly in the study of GTPase-Activating Protein SH3 Domain-Binding Proteins (G3BP). With a total of 2 patents, his work has implications for understanding cellular processes and potential therapeutic targets.
Latest Patents
Yang's latest patents focus on methods for identifying modulators of G3BP activity. One of his patents describes a method for identifying a lead or candidate compound that modulates the activity of G3BP. This method includes determining whether a compound modulates the interaction between the N-terminal Nuclear Transport Factor 2-like (NTF2L) domain of G3BP and the FGDF peptide of ubiquitin-specific protease 10 (USP10) or non-structural protein 3 (nsP3). This innovative approach could pave the way for new treatments in various diseases.
Career Highlights
Peiguo Yang is currently affiliated with St. Jude Children's Research Hospital, where he continues to advance his research. His work is characterized by a commitment to understanding complex biological mechanisms and developing potential therapeutic strategies.
Collaborations
Yang collaborates with esteemed colleagues, including J Paul Taylor and Wenwei Lin. These partnerships enhance the research environment and contribute to the advancement of knowledge in their field.
Conclusion
Peiguo Yang's contributions to the field of GTPase-Activating Protein research highlight his innovative spirit and dedication to scientific advancement. His patents and ongoing work at St. Jude Children's Research Hospital reflect his commitment to improving health outcomes through research.